Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Andrographolides + Capecitabine in Elderly Colorectal Cancer
NCT01993472Phase 2Terminated
- Start
- Nov 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of andrographolide in colorectal cancer (CRC). Started Nov 2013; status: terminated.
02
Drugs
andrographolide
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01993472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01993472.